Bienville Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-2,000
Closed -$244K – 90
2023
Q3
$244K Hold
2,000
– – 0.07% 83
2023
Q2
$281K Hold
2,000
– – 0.09% 75
2023
Q1
$283K Hold
2,000
– – 0.1% 78
2022
Q4
$313K Hold
2,000
– – 0.09% 71
2022
Q3
$245K Hold
2,000
– – 0.1% 90
2022
Q2
$266K Hold
2,000
– – 0.13% 109
2022
Q1
$274K Hold
2,000
– – 0.13% 118
2021
Q4
$346K Hold
2,000
– – 0.25% 74
2021
Q3
$291K Hold
2,000
– – 0.17% 82
2021
Q2
$264K Hold
2,000
– – 0.02% 123
2021
Q1
$257K Hold
2,000
– – 0.03% 127
2020
Q4
$238K Hold
2,000
– – 0.02% 105
2020
Q3
$229K Sell
2,000
-1,895
-49% -$224K 0.03% 108
2020
Q2
$444K Buy
3,895
+1,350
+53% +$143K 0.04% 74
2020
Q1
$204K Buy
2,545
+545
+27% +$56.4K 0.04% 98
2019
Q4
$214K Hold
2,000
– – 0.05% 79
2019
Q3
$214K Sell
2,000
-42
-2% -$4.31K 0.02% 76
2019
Q2
$208K Buy
+2,042
New +$196K 0.03% 196
2018
Q4
– Sell
-2,000
Closed -$216K – 174
2018
Q3
$216K Hold
2,000
– – 0.02% 103
2018
Q2
$220K Hold
2,000
– – 0.02% 114
2018
Q1
$201K Buy
+2,000
New +$205K 0.03% 124
2017
Q3
– Sell
-2,000
Closed -$222K – 184
2017
Q2
$222K Buy
+2,000
New +$211K 0.06% 152

Other funds holding DGX

Bienville Capital Management's DGX Position: Q4 2023 in Review

Bienville Capital Management sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 2,000 shares — an estimated $244K sold.

Bienville Capital Management first reported a position in DGX in Q2 2017 and held it in 22 quarters. The position peaked at $444K in Q2 2020. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • Bienville Capital Management reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
  • Bienville Capital Management sold 2,000 Quest Diagnostics shares in Q4 2023, an estimated $244K.
  • Bienville Capital Management first reported a position in Quest Diagnostics in Q2 2017 and held it in 22 quarters.
  • Bienville Capital Management's Quest Diagnostics position peaked at $444K in Q2 2020.
  • 827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Bienville Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.